The move advances a deliberate strategy to unify differentiated capabilities into a comprehensive visitor management platform for enterprise and SMB organizations. Sign In Solutions, a global standard for visitor management, today announced it has acquired The Receptionist, a Denver, Colo.-based visitor management company with more than 5,500 customers in 35 countries. The acquisition further solidifies […]
At the 2026 JP Morgan Healthcare Conference, CytoReason unveiled LINA, an AI agent designed to support pharmaceutical research and development. LINA is a computational biology assistant that interprets molecular, clinical, and patient-level data using CytoReason's AI disease models and NVIDIA NIM microservices. Built on CytoReason's AI framework and trained on hundreds of drug-development questions used
As demand surges during its 50th year in the U.S., ALDI is accelerating growth into new markets while modernizing the shopping experience through a redesigned website Key Points — In 2026, the company’s 50th anniversary in the U.S., ALDI will open more than 180 new stores across 31 states — ALDI announces its five-year plan
Collaboration is designed to improve analytical speed and accuracy of Freenome’s blood-based cancer screening tests – Freenome today announced an initiative to advance its blood-based early cancer screening program by leveraging NVIDIA deep learning technology and expertise to improve the recognition of cancer-specific patterns in the blood at the disease’s earliest stages. With NVIDIA accelerated
Today, Impilo announced the launch of a new AI-powered support experience for its e-commerce store, The Digital Health Store, bringing intelligent, always-on assistance to patients purchasing remote patient monitoring (RPM) devices online. At launch, the experience is powered by TaylorAI, Impilo’s Digital Health Concierge Agent, designed to help patients set up, understand, and troubleshoot their
Vitestro, a pioneer in medical robotics advancing automated diagnostic blood collection, today announced the launch of its new corporate website and the release of its first publicly available video. The video demonstrates the Aletta® Autonomous Robotic Phlebotomy Device(TM) (ARPD(TM)) performing a diagnostic blood draw. Together, these milestones represent an important step in Vitestro's evolution toward
Suvoda, a clinical trial technology company, took decisive steps in 2025 toward a more connected and streamlined clinical trial experience for both patients and sites. The company’s merger with Greenphire marked a pivotal moment in that journey, strengthening Suvoda’s ability to tackle persistent trial operational challenges with a more unified approach. Together with continued product
DC Capital Partners (“DC Capital” or “DCCP”), a private equity investment firm with deep expertise in Government and Engineering markets, announced today that it has completed the sale of Pond & Company (“Pond”) to Arlington Capital Partners. Terms of the transaction were not disclosed. Pond is an industry leader in engineering, architecture, planning and construction
Single tickets for all events are now on sale and all-access passes still available Today, Folger Theatre announces the complete lineup of events included in the fourth annual Reading Room Festival, a public celebration exploring how Shakespeare’s works are adapted, translated, and reimagined for the stage today. The Reading Room Festival will take place January
The companies will work together to help pharmaceutical organizations improve efficiency and deliver better outcomes for patients. TetraScience, the Scientific Data and AI company, today announced a collaboration with Thermo Fisher Scientific Inc., the world leader in serving science, with a goal of accelerating AI across biopharma R&D and manufacturing by transforming scientific data into